Buy, Sell or Hold: Arcus Biosciences (RCUS-N)

Home

Daily Stock Opinions and Ratings

Arcus Biosciences (RCUS-N)

10.06

+0.39 (4.03%)

as of Aug 13, 2025, 8:00:00 pm Market Open.

1 watching

Nervous markets await Nvidia

Most recent Opinions go here

Be up to date, don’t miss your chance.

RISKY

They're losing money. You can buy this as a spec stock only if you hold no other spec stock. Each portfolio is allowed one spec stock.

Showing 1 to 1 of 1 entries

Arcus Biosciences(RCUS-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Arcus Biosciences is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Arcus Biosciences(RCUS-N) Frequently Asked Questions

What is Arcus Biosciences stock symbol?

Arcus Biosciences is a American stock, trading under the symbol RCUS-N on the New York Stock Exchange (RCUS). It is usually referred to as NYSE:RCUS or RCUS-N

Is Arcus Biosciences a buy or a sell?

In the last year, 1 stock analyst published opinions about RCUS-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Arcus Biosciences.

Is Arcus Biosciences a good investment or a top pick?

Arcus Biosciences was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Arcus Biosciences.

Why is Arcus Biosciences stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Arcus Biosciences worth watching?

In the last year, there was no coverage of Arcus Biosciences published on Stockchase.

What is Arcus Biosciences stock price?

On 2025-08-13, Arcus Biosciences (RCUS-N) stock closed at a price of $10.06.

Most Recent Experts

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Kim Bolton

Black Swan Dexteritas

Stockchase Insights

5i Research

Jim Cramer - Mad Money

CNBC

Chris Blumas

at Raymond James Investment Counsel Ltd.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.